MENU
ENLV
AS OF
Dec 3 closing price
Price
$1.09
Change
+$0.14 (+14.74%)
Capitalization
258.74M
83 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ENLV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Enlivex Therapeutics (ENLV) Earnings Date & Reports

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company... Show more

A.I. Advisor
published Earnings

ENLV is expected to report earnings to rise 40.33% to -12 cents per share on February 25

Enlivex Therapeutics ENLV Stock Earnings Reports
Q4'25
Est.
$-0.13
Q3'25
Beat
by $0.05
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.07
The last earnings report on December 01 showed earnings per share of -9 cents, beating the estimate of -14 cents. With 2.38M shares outstanding, the current market capitalization sits at 258.74M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ENLV
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ENLV showed earnings on December 01, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ENLV
A.I. Advisor
published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
14 Einstein Street
Phone
+972 26208072
Employees
77
Web
https://www.enlivex.com